Literature DB >> 11052148

European best practice guidelines 14-16: inadequate response to epoetin.

W H Hörl, C Jacobs, I C Macdougall, F Valderrábano, I Parrondo, K Thompson, B G Carveth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11052148

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  13 in total

1.  A new concept for the differential diagnosis and therapy of anaemia in cancer patients.

Authors:  H Tilman Steinmetz; Antonis Tsamaloukas; Stephan Schmitz; Jörg Wiegand; Robert Rohrberg; Jochen Eggert; Friedhelm Breuer; Hans-Werner Tessen; Heidi Eustermann; Lothar Thomas
Journal:  Support Care Cancer       Date:  2010-02-11       Impact factor: 3.603

2.  Oral vitamin C supplementation reduces erythropoietin requirement in hemodialysis patients with functional iron deficiency.

Authors:  Tanjim Sultana; Maria V DeVita; Michael F Michelis
Journal:  Int Urol Nephrol       Date:  2016-05-11       Impact factor: 2.370

Review 3.  Clinical recommendations for the use of recombinant human erythropoietin in patients with hepatitis C virus being treated with ribavirin.

Authors:  Morris Sherman; Lawrence Cohen; Mary Anne Cooper; Magdy Elkashab; Victor Feinman; David Fletcher; Nigel Girgrah; Jenny Heathcote; Mark Levstik; William B McNaull; David Wong; Florence Wong; Colina Yim
Journal:  Can J Gastroenterol       Date:  2006-07       Impact factor: 3.522

4.  Variant hemoglobin phenotypes may account for differential erythropoiesis-stimulating agent dosing in African-American hemodialysis patients.

Authors:  Vimal K Derebail; Patrick H Nachman; Nigel S Key; Heather Ansede; Ronald J Falk; Wayne D Rosamond; Abhijit V Kshirsagar
Journal:  Kidney Int       Date:  2011-08-17       Impact factor: 10.612

Review 5.  Iron-refractory iron deficiency anemia: new molecular mechanisms.

Authors:  Yujie Cui; Qingyu Wu; Yiqing Zhou
Journal:  Kidney Int       Date:  2009-09-23       Impact factor: 10.612

6.  Erythropoiesis-stimulating agents in anaemia due to chronic kidney disease: a cost-minimization analysis.

Authors:  Vicente Escudero-Vilaplana; Concepción Martínez-Nieto; Juan Manuel López-Gómez; Almudena Vega-Martínez; José María Bellón-Cano; María Sanjurjo-Sáez
Journal:  Int J Clin Pharm       Date:  2013-04-18

7.  Factors related to erythropoietin hypo-responsiveness in patients on chronic peritoneal dialysis.

Authors:  Mingxin Wei; Joanne M Bargman; Dimitrios G Oreopoulos
Journal:  Int Urol Nephrol       Date:  2007-05-30       Impact factor: 2.370

8.  Long-term L-carnitine administration reduces erythropoietin resistance in chronic hemodialysis patients with thalassemia minor.

Authors:  Biagio R Di Iorio; Pasquale Guastaferro; Nicola Cillo; Emanuele Cucciniello; Vincenzo Bellizzi
Journal:  Drug Target Insights       Date:  2007-01-24

9.  Oral zinc supplementation reduces the erythropoietin responsiveness index in patients on hemodialysis.

Authors:  Hiroki Kobayashi; Masanori Abe; Kazuyoshi Okada; Ritsukou Tei; Noriaki Maruyama; Fumito Kikuchi; Terumi Higuchi; Masayoshi Soma
Journal:  Nutrients       Date:  2015-05-15       Impact factor: 5.717

10.  Partially thrombosed aneurysm of the abdominal aorta: Unusual cause of chronic inflammation and resistance to recombinant human erythropoietin.

Authors:  M El Amrani; A El Kharras; M Asserraji
Journal:  Indian J Nephrol       Date:  2014-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.